In patients with type 2 diabetes or myocardial infarction, plasma β2GP I and oxidized low-density lipoprotein (oxLDL)/β2GP I complex levels are significantly increased; these are predicted adverse consequences of cardiovascular events [5]. The gene discussed is APOH; the disease is type 2 diabetes mellitus.